Minnesota Partnership - Academic Health Center - University of Minnesota
Frank B. Cerra and Robert Rizza, Mayo Clinic executive dean of research, speak to an audience on the economic impact of the Minnesota Partnership.
The Minnesota Partnership is a collaboration of the state, the University of Minnesota, and Mayo Clinic.
The goal is to position Minnesota as a world leader in biotechnology that will result in:
- important new medical discoveries
- improved health care for patients
- development of new business and jobs in Minnesota
Research teams with investigators from both institutions are studying: Alzheimer's disease, several types of cancer and cancer drug development, heart disease, obesity, infectious diseases, muscle diseases, nanotechnology, and addiction.
Results
- Researchers have published 94 peer-reviewed papers in scientific journals. Partnership researchers have also made more than 100 presentations worldwide.
- More than $100 million in external funding from National Institutes of Health, donors, and industry
- For every $1 million in funding, nearly 16 jobs are created for the state of Minnesota.
- 3 patents, 1 formal licensing application and 1 project transitioning to commercialization.
- Awarded funding for 45 research projects and 14 competitive infrastructure improvement projects
